INTRODUCTION

Insulin glargine (brand names Basaglar, Lantus, Rezvoglar, Semglee, Soliqua, Toujeo) is a long-acting form of insulin analogue that is used for the treatment of hyperglycemia caused by Type 1 and Type 2 diabetes mellitus.

This plasmid is designed for expressing Insulin glargine in E.coli expression system.

PRODUCT INFORMATION

Item No.: PPBD-98
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Insulin glargine
Brand Name(s): Basaglar, Lantus, Rezvoglar, Semglee, Soliqua, Toujeo
Classification: Insulins
Amino Acid Sequence: Identical to DB00047

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Chatterjee S, Tringham JR, Davies MJ. Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus. Expert Opin Pharmacother. 2006 Jul;7(10):1357-71.

[2] Home PD, Ashwell SG. An overview of insulin glargine. Diabetes Metab Res Rev. 2002 Sep-Oct;18 Suppl 3:S57-63.

Contact Us